Immunomodulation by H. pylori, particularly strains expressing the CagA virulence factor, appears pivotal in eliciting Treg cell responses and attenuating pro-inflammatory pathways implicated in IBD pathogenesis [7]. This evidence concerns the gene S100A8 and inflammatory bowel disease.